Tulrampator
id:
tulrampator-180-11310995
title:
Tulrampator
text:
Tulrampator is a positive allosteric modulator (PAM) of the AMPA receptor (AMPAR), an ionotropic glutamate receptor, which is under development by RespireRx Pharmaceuticals and Servier for the treatment of major depressive disorder, Alzheimer's disease, dementia, and mild cognitive impairment. Tulrampator was in phase II clinical trial for depression, but failed to show superiority over placebo. There are also phase II clinical trials for Alzheimer's disease and phase I trials for dementia and m
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Tulrampator
date created:
2017-08-31T03:24:27Z
date modified:
2024-09-05T14:16:07Z
main entity:
{"identifier":"Q39050057","url":"https://www.wikidata.org/entity/Q39050057"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/4e/Tulrampator_skeletal.svg","width":631,"height":253}
fields total:
13
integrity:
16